• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRC2介导的H3K27甲基化在细胞特性及癌症中的作用

PRC2 mediated H3K27 methylations in cellular identity and cancer.

作者信息

Conway Eric, Healy Evan, Bracken Adrian P

机构信息

Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.

Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.

出版信息

Curr Opin Cell Biol. 2015 Dec;37:42-8. doi: 10.1016/j.ceb.2015.10.003. Epub 2015 Nov 11.

DOI:10.1016/j.ceb.2015.10.003
PMID:26497635
Abstract

The Polycomb Repressive Complex 2 (PRC2) is a multiprotein chromatin modifying complex that is essential for vertebrate development and differentiation. It is composed of a trimeric core of SUZ12, EED and EZH1/2 and is responsible for catalysing both di-methylation and tri-methylation of Histone H3 at lysine 27 (H3K27me2/3). Both H3K27 methylations contribute to the role of PRC2 in maintaining cellular identity. In all cell types, the H3K27me3 modification is associated with repression of genes encoding regulators of alternative lineages. The less well-characterised H3K27me2 modification is ubiquitous throughout the genome and is thought to act like a protective blanket to maintain the repression of non-H3K27me3 associated genes and cell-type-specific enhancers of alternative lineages. Recent cancer genome sequencing studies highlighted that several genes encoding PRC2 components as well as Histone H3 are mutated in multiple cancer types. Intriguingly, these cancers have changes in the global levels of the H3K27me2 and H3K27me3 modifications as well as genome-wide redistributions. Exciting new studies suggest that these changes confer context dependent blocks in cellular differentiation and increased vulnerability to aberrant cancer signalling pathways.

摘要

多梳抑制复合物2(PRC2)是一种多蛋白染色质修饰复合物,对脊椎动物的发育和分化至关重要。它由SUZ12、EED和EZH1/2的三聚体核心组成,负责催化组蛋白H3赖氨酸27位的二甲基化和三甲基化(H3K27me2/3)。这两种H3K27甲基化都有助于PRC2在维持细胞特性方面发挥作用。在所有细胞类型中,H3K27me3修饰与编码替代谱系调节因子的基因的抑制相关。特征较少的H3K27me2修饰在整个基因组中普遍存在,被认为起到保护作用,以维持与非H3K27me3相关基因和替代谱系的细胞类型特异性增强子的抑制。最近的癌症基因组测序研究表明,多个癌症类型中编码PRC2组分以及组蛋白H3的几个基因发生了突变。有趣的是,这些癌症在H3K27me2和H3K27me3修饰的整体水平以及全基因组重新分布方面都有变化。令人兴奋的新研究表明,这些变化在细胞分化中赋予了依赖于背景的阻滞作用,并增加了对异常癌症信号通路的易感性。

相似文献

1
PRC2 mediated H3K27 methylations in cellular identity and cancer.PRC2介导的H3K27甲基化在细胞特性及癌症中的作用
Curr Opin Cell Biol. 2015 Dec;37:42-8. doi: 10.1016/j.ceb.2015.10.003. Epub 2015 Nov 11.
2
Structural basis for PRC2 engagement with chromatin.PRC2 与染色质结合的结构基础。
Curr Opin Struct Biol. 2021 Apr;67:135-144. doi: 10.1016/j.sbi.2020.10.017. Epub 2020 Nov 21.
3
The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells.H3K36me2 甲基转移酶 Nsd1 在胚胎干细胞中划定 PRC2 介导的 H3K27me2 和 H3K27me3 结构域。
Mol Cell. 2018 Apr 19;70(2):371-379.e5. doi: 10.1016/j.molcel.2018.02.027. Epub 2018 Mar 29.
4
PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation.PRC2.1 和 PRC2.2 协同作用以协调 H3K27 三甲基化。
Mol Cell. 2019 Nov 7;76(3):437-452.e6. doi: 10.1016/j.molcel.2019.08.012. Epub 2019 Sep 11.
5
A Family of Vertebrate-Specific Polycombs Encoded by the LCOR/LCORL Genes Balance PRC2 Subtype Activities.LCOR/LCORL 基因编码的脊椎动物特异性 Polycomb 家族平衡 PRC2 亚基活性。
Mol Cell. 2018 May 3;70(3):408-421.e8. doi: 10.1016/j.molcel.2018.03.005. Epub 2018 Apr 5.
6
Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.解析 H3K27 乙酰化和甲基化在 PRC2 介导的细胞身份控制中的作用。
Nat Commun. 2019 Apr 11;10(1):1679. doi: 10.1038/s41467-019-09624-w.
7
The role of EZH1 and EZH2 in development and cancer.EZH1 和 EZH2 在发育和癌症中的作用。
BMB Rep. 2022 Dec;55(12):595-601. doi: 10.5483/BMBRep.2022.55.12.174.
8
Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.通过PRC2复合体的Jarid2甲基化在细胞分化过程中调节H3K27me3沉积。
Mol Cell. 2015 Mar 5;57(5):769-783. doi: 10.1016/j.molcel.2014.12.020. Epub 2015 Jan 22.
9
Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma.PRC2 的自动甲基化促进了 H3K27 的甲基化,并在 H3K27M 型小儿神经胶质瘤中受损。
Genes Dev. 2019 Oct 1;33(19-20):1428-1440. doi: 10.1101/gad.328773.119. Epub 2019 Sep 5.
10
EZH1 in germ cells safeguards the function of PRC2 during spermatogenesis.生殖细胞中的EZH1在精子发生过程中保障PRC2的功能。
Dev Biol. 2017 Apr 15;424(2):198-207. doi: 10.1016/j.ydbio.2017.02.017. Epub 2017 Feb 28.

引用本文的文献

1
Interaction and regulatory expression of Polycomb and NuRD complexes in mouse embryonic stem cell under PKC inhibition.蛋白激酶C抑制下小鼠胚胎干细胞中多梳蛋白和核小体重塑去乙酰化酶复合物的相互作用及调控表达
Sci Rep. 2025 Jul 26;15(1):27204. doi: 10.1038/s41598-025-12427-3.
2
Epigenetic regulation and mechanobiological adaptation in tenocytes during maturation.成熟过程中肌腱细胞的表观遗传调控与力学生物学适应
APL Bioeng. 2025 Jun 26;9(2):026127. doi: 10.1063/5.0271050. eCollection 2025 Jun.
3
A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.
一种含有CBX4的特定形式的cPRC1被用于介导弥漫性中线胶质瘤中的致癌基因抑制。
Mol Cell. 2025 Jun 5;85(11):2110-2127.e7. doi: 10.1016/j.molcel.2025.04.026. Epub 2025 May 21.
4
Translating Basic Science Discoveries into Clinical Advances: Highlights from the EACR-AACR-IACR 2024 Conference in Celebration of Irish Association for Cancer Research's 60th Anniversary.将基础科学发现转化为临床进展:2024年欧洲癌症研究协会-美国癌症研究协会-国际癌症研究协会会议亮点,庆祝爱尔兰癌症研究协会成立60周年
Cancers (Basel). 2025 Apr 24;17(9):1420. doi: 10.3390/cancers17091420.
5
A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis.肾髓质癌脑转移中胶质细胞转分化的一例新病例。
Acta Neuropathol Commun. 2025 Jan 20;13(1):12. doi: 10.1186/s40478-025-01929-w.
6
A conserved switch to less catalytically active Polycomb repressive complexes in non-dividing cells.在非分裂细胞中向催化活性较低的多梳抑制复合物的保守转变。
Cell Rep. 2025 Jan 28;44(1):115192. doi: 10.1016/j.celrep.2024.115192. Epub 2025 Jan 11.
7
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond.组蛋白去乙酰化酶驱动的抗癌耐药机制:表观遗传学及其他。
Cancer Drug Resist. 2024 Nov 20;7:46. doi: 10.20517/cdr.2024.103. eCollection 2024.
8
WTAP-dependent N6-methyladenosine methylation of lncRNA TEX41 promotes renal cell carcinoma progression.WTAP 依赖性 lncRNA TEX41 的 N6-甲基腺苷甲基化促进肾细胞癌进展。
Sci Rep. 2024 Oct 21;14(1):24742. doi: 10.1038/s41598-024-76326-9.
9
How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia.氧合如何塑造免疫反应:生理性氧分压和病理性缺氧的新作用
Nat Rev Immunol. 2025 Mar;25(3):161-177. doi: 10.1038/s41577-024-01087-5. Epub 2024 Sep 30.
10
Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).组蛋白甲基化修饰与糖尿病肾病:潜在的分子机制和治疗方法(综述)。
Int J Mol Med. 2024 Nov;54(5). doi: 10.3892/ijmm.2024.5428. Epub 2024 Sep 20.